254 related articles for article (PubMed ID: 10201343)
1. Pharmacokinetics of intermittent intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients.
Manley HJ; Bailie GR; Asher RD; Eisele G; Frye RF
Perit Dial Int; 1999; 19(1):65-70. PubMed ID: 10201343
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of once daily intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients.
Low CL; Gopalakrishna K; Lye WC
J Am Soc Nephrol; 2000 Jun; 11(6):1117-1121. PubMed ID: 10820176
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of intermittent intraperitoneal ceftazidime.
Grabe DW; Bailie GR; Eisele G; Frye RF
Am J Kidney Dis; 1999 Jan; 33(1):111-7. PubMed ID: 9915275
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of intraperitoneal cefazolin and gentamicin in empiric therapy of peritonitis in continuous ambulatory peritoneal dialysis patients.
Tosukhowong T; Eiam-Ong S; Thamutok K; Wittayalertpanya S; Na Ayudhya DP
Perit Dial Int; 2001; 21(6):587-94. PubMed ID: 11783768
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of intraperitoneal cefazolin and ceftazidime coadministered to CAPD patients.
Elwell RJ; Manley HJ; Frye RF; Bailie GR
Int J Artif Organs; 2005 Aug; 28(8):808-16. PubMed ID: 16211531
[TBL] [Abstract][Full Text] [Related]
6. Short-Dwell Cycling Intraperitoneal Cefazolin Plus Ceftazidime in Peritoneal Dialysis Patients.
Peerapornratana S; Chariyavilaskul P; Kanjanabuch T; Praditpornsilpa K; Eiam-Ong S; Katavetin P
Perit Dial Int; 2017; 37(2):218-224. PubMed ID: 27738089
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of intraperitoneal cefepime in automated peritoneal dialysis.
Elwell RJ; Frye RF; Bailie GR
Perit Dial Int; 2005; 25(4):380-6. PubMed ID: 16022096
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of intermittent intravenous cefazolin and tobramycin in patients treated with automated peritoneal dialysis.
Manley HJ; Bailie GR; Frye R; Hess LD; McGoldrick MD
J Am Soc Nephrol; 2000 Jul; 11(7):1310-1316. PubMed ID: 10864588
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of intraperitoneal fluconazole during continuous cycling peritoneal dialysis.
Dahl NV; Foote EF; Searson KM; Fein JL; Kapoian T; Steward CA; Sherman RA
Ann Pharmacother; 1998 Dec; 32(12):1284-9. PubMed ID: 9876807
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of once-daily IP gentamicin in CAPD patients.
Low CL; Bailie GR; Evans A; Eisele G; Venezia RA
Perit Dial Int; 1996; 16(4):379-84. PubMed ID: 8863331
[TBL] [Abstract][Full Text] [Related]
11. Intraperitoneal cefazolin and ceftazidime during short-dwell exchange in peritoneal dialysis patients with peritonitis.
Triyawatanyu P; Chariyavilaskul P; Phaisal W; Peerapornratana S; Kanjanabuch T; Praditpornsilpa K; Katavetin P
Perit Dial Int; 2020 Mar; 40(2):179-184. PubMed ID: 32063189
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of teicoplanin in patients undergoing continuous ambulatory peritoneal dialysis.
Stamatiadis D; Papaioannou MG; Giamarellos-Bourboulis EJ; Marinaki S; Giamarellou H; Stathakis CP
Perit Dial Int; 2003; 23(2):127-31. PubMed ID: 12713078
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic analysis of ceftazidime and cefazolin in the treatment of continuous ambulatory peritoneal dialysis-related peritonitis.
Zhu W; Fang X; Zheng J; Ke Y; He Q; Cui T; Chen B; Tian L
Ren Fail; 2023; 45(2):2285873. PubMed ID: 38044852
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of Intraperitoneal Cefalothin and Cefazolin in Patients Being Treated for Peritoneal Dialysis-Associated Peritonitis.
Roberts DM; Ranganathan D; Wallis SC; Varghese JM; Kark A; Lipman J; Roberts JA
Perit Dial Int; 2016; 36(4):415-20. PubMed ID: 26764340
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of cefepime in patients undergoing continuous ambulatory peritoneal dialysis.
Barbhaiya RH; Knupp CA; Pfeffer M; Zaccardelli D; Dukes GM; Mattern W; Pittman KA; Hak LJ
Antimicrob Agents Chemother; 1992 Jul; 36(7):1387-91. PubMed ID: 1510432
[TBL] [Abstract][Full Text] [Related]
16. Vancomycin disposition following intraperitoneal administration in children receiving peritoneal dialysis.
Blowey DL; Warady BA; Abdel-Rahman S; Frye RF; Manley HJ
Perit Dial Int; 2007; 27(1):79-85. PubMed ID: 17179516
[TBL] [Abstract][Full Text] [Related]
17. Unidirectional absorption of gentamicin from the peritoneum during continuous ambulatory peritoneal dialysis.
Somani P; Shapiro RS; Stockard H; Higgins JT
Clin Pharmacol Ther; 1982 Jul; 32(1):113-21. PubMed ID: 7083725
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of icodextrin in peritoneal dialysis patients.
Moberly JB; Mujais S; Gehr T; Hamburger R; Sprague S; Kucharski A; Reynolds R; Ogrinc F; Martis L; Wolfson M
Kidney Int Suppl; 2002 Oct; (81):S23-33. PubMed ID: 12230479
[TBL] [Abstract][Full Text] [Related]
19. Correlation of intraperitoneal antibiotic pharmacokinetics and peritoneal membrane transport characteristics.
Elwell RJ; Bailie GR; Manley HJ
Perit Dial Int; 2000; 20(6):694-8. PubMed ID: 11216561
[TBL] [Abstract][Full Text] [Related]
20. Clearance from dialysate and equilibration of intraperitoneal vancomycin in continuous ambulatory peritoneal dialysis.
Neal D; Bailie GR
Clin Pharmacokinet; 1990 Jun; 18(6):485-90. PubMed ID: 2354591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
